1. Home
  2. SGMT vs ASM Comparison

SGMT vs ASM Comparison

Compare SGMT & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • ASM
  • Stock Information
  • Founded
  • SGMT 2006
  • ASM 1968
  • Country
  • SGMT United States
  • ASM Canada
  • Employees
  • SGMT N/A
  • ASM N/A
  • Industry
  • SGMT
  • ASM Metal Mining
  • Sector
  • SGMT
  • ASM Basic Materials
  • Exchange
  • SGMT Nasdaq
  • ASM Nasdaq
  • Market Cap
  • SGMT 159.0M
  • ASM 146.2M
  • IPO Year
  • SGMT 2023
  • ASM N/A
  • Fundamental
  • Price
  • SGMT $4.39
  • ASM $1.10
  • Analyst Decision
  • SGMT Buy
  • ASM Strong Buy
  • Analyst Count
  • SGMT 6
  • ASM 2
  • Target Price
  • SGMT $23.00
  • ASM $1.80
  • AVG Volume (30 Days)
  • SGMT 1.2M
  • ASM 1.2M
  • Earning Date
  • SGMT 11-13-2024
  • ASM 11-12-2024
  • Dividend Yield
  • SGMT N/A
  • ASM N/A
  • EPS Growth
  • SGMT N/A
  • ASM 144.19
  • EPS
  • SGMT N/A
  • ASM 0.02
  • Revenue
  • SGMT N/A
  • ASM $54,326,000.00
  • Revenue This Year
  • SGMT N/A
  • ASM $40.31
  • Revenue Next Year
  • SGMT N/A
  • ASM $33.83
  • P/E Ratio
  • SGMT N/A
  • ASM $43.14
  • Revenue Growth
  • SGMT N/A
  • ASM 18.08
  • 52 Week Low
  • SGMT $2.39
  • ASM $0.44
  • 52 Week High
  • SGMT $20.71
  • ASM $1.56
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 44.30
  • ASM 60.13
  • Support Level
  • SGMT $4.06
  • ASM $0.88
  • Resistance Level
  • SGMT $7.38
  • ASM $1.21
  • Average True Range (ATR)
  • SGMT 0.63
  • ASM 0.06
  • MACD
  • SGMT -0.11
  • ASM 0.03
  • Stochastic Oscillator
  • SGMT 9.94
  • ASM 69.44

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

Share on Social Networks: